Amgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts

Amgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts

The article discusses Amgen Inc. as one of the undervalued wide moat stocks, highlighting its strong portfolio and growth potential. Analysts believe in its revenue growth, with projections for 2024.

Read More

Did you find this insightful?